Cellular/Molecular

Identification of Ectodomain Regions Contributing to Gating, Deactivation, and Resensitization of Purinergic P2X Receptors

Hana Zemkova, Mu-Lan He, Taka-aki Koshimizu and Stanko S. Stojilkovic
Journal of Neuroscience 4 August 2004, 24 (31) 6968-6978; DOI: https://doi.org/10.1523/JNEUROSCI.1471-04.2004

Abstract

The P2X receptors (P2XRs) are a family of ligand-gated channels activated by extracellular ATP through a sequence of conformational transitions between closed, open, and desensitized states. In this study, we examined the dependence of the activity of P2XRs on ectodomain structure and agonist potency. Experiments were done in human embryonic kidney 293 cells expressing rat P2X2aR, P2X2bR, and P2X3R, and chimeras having the V60-R180 or V60-F301 ectodomain sequences of P2X3R instead of the I66-H192 or I66-Y310 sequences of P2X2aR and P2X2bR. Chimeric P2X2a/V60-F301X3R and P2X2b/V60-F301X3R inherited the P2X3R ligand-selective profile, whereas the potency of agonists for P2X2a/V60-R180X3R was in between those observed at parental receptors. Furthermore, P2X2a/V60-F301X3R and P2X2a/V60-R180X3R desensitized in a P2X2aR-specific manner, and P2X2b/V60-F301X3R desensitized with rates comparable with those of P2X2bR. In striking contrast to parental receptors, the rates of decay in P2X2a/V60-F301X3R and P2X2b/V60-F301X3R currents after agonist withdrawal were 15- to 200-fold slower. For these chimeras, the decays in currents were not dependent on duration of stimuli and reflected both continuous desensitization and deactivation of receptors. Also, participation of deactivation in closure of channels inversely correlated with potency of agonists to activate receptors. The delay in deactivation was practically abolished in P2X2a/V60-R180X3R-expressing cells. However, the recovery from desensitization of P2X2a/V60-F301X3R and P2X2a/V60-R180X3R was similar and substantially delayed compared with that of parental receptors. These results indicate that both ectodomain halves participate in gating, but that the C and N halves influence the stability of open and desensitized conformation states, respectively, which in turn reflects on rates of receptor deactivation and resensitization.

Introduction

Purinergic P2 receptors (P2XRs) are a family of ion-conducting channels that activate and desensitize in response to the binding of ATP to the extracellular ligand-binding domain, and deactivate and resensitize after washout of agonist. The P2XR subunits are composed of two transmembrane domains, placing most of the protein extracellularly and the N and C termini intracellularly. The trimeric assembly of subunits most likely accounts for formation of functional P2XR channels (Nicke et al., 1998), and two to three molecules of ATP are required to activate receptor (Bean, 1990). In the absence of crystallographic data, the dependence of conformation transitions between resting, conducting, and desensitized states on P2XR structure have been incompletely understood (North, 2002). P2XRs differ in their sensitivity for ATP with EC50 values in the following order: P2X1R = P2X3R < P2X2R < P2X4R = P2X5R < P2X6R << P2X7R. There are other pharmacological distinctions among receptors, such as the sensitivity to αβ-methylene-ATP and antagonists (Khakh et al., 2001), suggesting the structural specificity of the ligand-binding pocket. The ATP binding site was partially characterized (Jiang et al., 2001; Roberts and Evans, 2004), and P2XR ectodomain also contains sites for antagonists and modulators (Garcia-Guzman et al., 1997; Clarke et al., 2000; Coddou et al., 2003). The relevance of residues that line the channel walls was also studied (Rassendren et al., 1997; Egan et al., 1998).

Receptors differ in their desensitization rates: P2X1R and P2X3R desensitize rapidly, and P2X4R and P2X5R desensitize with moderate rates, whereas P2X2R, P2X6R, and P2X7R desensitize slowly or do not desensitize (Ralevic and Burnstock, 1998). The site-directed mutagenesis revealed an important role for residues in the C-terminal domain of P2XRs (Brandle et al., 1997; Simon et al., 1997; Koshimizu et al., 1998, 1999). However, other domains also participate in desensitization (Werner et al., 1996; Boue-Grabot et al., 2000). The recovery from desensitization occurs in a minute timescale (North, 2002), but structural elements controlling the desensitized conformation state have not been identified. The deactivation of P2XRs is also incompletely characterized. In general, for nondesensitizing receptors, the deactivation rate should depend on the kinetics of transition from open to closed states and the rate of ligand dissociation from its binding site (Lester and Jahr, 1992). For P2XR, Rettinger and Schmalzing (2004) suggested that deactivation reflects predominantly the unbinding properties of the agonist. Their conclusion was based on finding that potency of several agonists to activate a nondesensitizing P2X2/P2X1 chimera inversely correlates with the corresponding time constant of deactivation.

Here, we used the recombinant rat P2X2aR, P2X2bR, and P2X3R, and their chimeras to study the dependence of the activity of channels on ectodomain structure. Our results indicate that changes in the receptor architecture made by chimerization had no obvious effects on receptor activation and kinetics of desensitization. However, chimerization dramatically delayed the deactivation of receptors and recovery from desensitization compared with parental P2XRs. These changes are consistent with a hypothesis that conformational changes associated with channel opening and desensitization trap agonist onto the P2XR and thus represent the rate-limiting steps in the deactivation and resensitization of receptors.

Materials and Methods

DNA constructs, cell culture, and transfection. The coding sequences of the rat P2X2a, P2X2b, and P2X3 subunits were isolated by reverse transcription-PCR (Koshimizu et al., 1999), and subcloned into the biscistronic enhanced fluorescent protein expression vector pIRES2-EGFP (Clontech, Palo Alto, CA) at the restriction enzyme sites of XhoI/PstI for P2X2aR and P2X2bR, and XhoI/EcoRI for P2X3R. Chimeric P2X2a/P2X3 and P2X2b/P2X3 subunits, termed P2X2a/V60-F301X3 and P2X2b/V60-F301X3, contain the extracellular domain from Val60 to Phe301 of P2X3R instead of the native Ile66-Tyr310 sequence of P2X2aR and P2X2bR, whereas in the P2X2a/V60-R180X3 chimera, the Val60-Arg180 sequence of P2X3R was substituted for the IIe66-His192 sequence of P2X2aR (Fig. 1 A). These chimeras were constructed as discussed previously (Koshimizu et al., 2002). The large-scale plasmid DNAs for transfection were prepared using a Qiagen (Hilden, Germany) Plasmid Maxi kit. Human embryonic kidney 293 cells (HEK293 cells) were used in functional studies of wild-type and mutant P2XRs, as previously described (He et al., 2003). HEK293 cells were cultured in MEM supplemented with 10% horse serum and 100 μg/ml gentamicin. Before the day of transfection, cells were plated on 35 mm culture dishes. For each dish of cells, transient transfection of expression constructs was conducted using 1 μg of DNA and 7 μl of Lipofectamine 2000 Reagent (Invitrogen, Carlsbad, CA) in 3 ml of serum-free Opti-MEM. After 6 hr of incubation, the transfection mixture was replaced with normal culture medium. Cells were subjected to experiments 24-48 hr after transfection. Experiments were performed in cells with comparable GFP (green fluorescent protein) fluorescence signals (∼60 arbitrary units).

Figure 1.
Figure 1.

Potency of agonists at parental and chimeric P2XRs. A, Schematic representation of the wild-type and chimeric constructs used in this study. For details, see Materials and Methods. B, Concentration dependence of ATP-induced peak response in cells expressing wild-type P2X3 (•, wild-type P2X2a and P2X2b combined (□), chimeric P2X2a/V60-F301X3 and P2X2b/V60-F301X3 combined (○), and chimeric P2X2a/V60-R180X3 (▪) receptors. Data shown are means ± SEM, n = 5-10 per dose, and peak amplitudes to 100 μm ATP application were used to normalize responses. Dotted lines illustrate EC50 values. C, The EC50 values for several agonists of parental and chimeric receptors. Data shown are mean values with SEM within 10%. Cells expressing P2X2a/V60-F301X3 and P2X2b/V60-F301X3 chimeras were stimulated with single agonist concentrations because of their unresponsiveness during repetitive agonist stimulation. The maximum in peak responses of P2X2Rs, P2X3R, and P2X2a/V60-R180X3 chimeras at saturating agonist concentrations were comparable, whereas the maximal P2X2a/V60-F301X3, and P2X2b/V60-F301X3 currents were 50-60% of that observed in parental receptors.

Current measurements. Electrophysiological experiments were performed at room temperature using whole-cell patch-clamp recording techniques. Cells were stimulated with ATP, αβ-methylene-ATP (αβ-meATP), 3′-O-(4-benzoyl)benzoyl-ATP (BzATP), adenosine-5′-O-(3-thiotriphosphate) (ATPγS), and 2-methylthio-ATP (2MeSATP) (Calbiochem, La Jolla, CA). Agonist-induced currents were recorded using an Axopatch 200B patch-clamp amplifier (Axon Instruments, Union City, CA) and were filtered at 1 kHz using a low-pass Bessel filter and sampled at 2 kHz. A 40-70% series resistance compensation was used. Patch electrodes, fabricated from borosilicate glass (type 1B150F-3; World Precision Instruments, Sarasota, FL) using a Flaming Brown horizontal puller (P-87; Sutter Instruments, Novato, CA), were heat polished to a final tip resistance of 3-5 MΩ. All of the current records were captured and stored using the pClamp 8 software packages in conjunction with the Digidata 1322A analog-to-digital converter (Axon Instruments). Patch electrodes were filled with a solution containing (in mm): 140 KCl, 0.5 CaCl2, 1 MgCl2, 5 EGTA, and 10 HEPES; pH was adjusted with 1 m KOH to 7.2. The osmolarity of the internal solutions was 282-287 mOsm. The bath solution contained (in mm): 142 NaCl, 3 KCl, 1 MgCl2, 2 CaCl2, 10 glucose, and 10 HEPES; pH was adjusted to 7.3 with 1 m NaOH. The osmolarity of this solution was 285-295 mOsm. A 3 m KCl agar bridge was placed between the bathing solution and the reference electrode. To avoid the impact of endogenously released ATP on the pattern of current signaling in all of the experiments, cells were perfused at a rate of ∼2 ml/min for at least 10 or 20 min before recording, depending on receptor subtypes. Agonists were applied for 2-60 sec using a fast gravity-driven microperfusion system (BPS-8; ALA Scientific Instruments, Westbury, NY). The application tip was routinely positioned ∼500 μm above the recorded cell. Less than 200 msec was required for exchange of solutions around the patched cells, as estimated from altered potassium current (20-80% rise time).

Calculations. Concentration-response data were fitted by a four-parameter logistic equation using a nonlinear curve-fitting program that derives the EC50 and Hill's values (Kaleidagraph; Synergy Software, Reading, PA). The profiles of currents evoked by prolonged agonist application (used as a measure of desensitization) and the kinetics of current decay evoked by washout of agonists were fitted by a single exponential function [y = A1 exp(-t/τ) + P] or by the sum of two exponentials [y = A1 exp(-t/τ1) + A2 exp(-t/τ2) + P] using the program CLAMPFIT 8 (Axon Instruments), where A1 and A2 are the relative amplitudes of the first and second exponential, τ1 and τ2 are time constants, and P is plateau. The derived time constant for desensitization was labeled τdes, and for current decay after agonist withdrawal, τoff. The recovery from desensitization was fitted using the equation I = Imax [1 - exp(t/τrec)], where I is the observed peak current response, Imax is the maximum peak current recovery, t is the washing time, and τrec is the recovery time constant. All of the numerical values in the text are reported as mean ± SEM, and significant differences, with p < 0.05, were determined by Student's t test.

Results

The efficacy of purinergic agonists for wild-type and chimeric P2XRs

When expressed in HEK293 cells under identical experimental conditions, parental P2X2aR, P2X2bR, and P2X3R responded to ATP with a rapid rise in current, with peak amplitude dependent on agonist concentrations. In P2X2aR- and P2X2bR-expressing cells, the peak current responses were comparable in individual ATP concentrations studied. Figure 1B illustrates the ATP concentration dependence of current amplitude for both receptor subtypes combined. The threshold ATP concentration required for their activation was 0.1 μm and the EC50 value was 2.6 μm. Other agonists also activated these receptors in a micromolar concentration range, with EC50 values indicated in Figure 1C; 2MeSATP was the most potent agonist for P2X2Rs, followed by ATP, ATPγS, and BzATP, whereas αβ-meATP acted at these receptors as a low potency agonist. P2X3R also responded to agonist application in a dose-response manner. In our experimental conditions, the threshold concentration of ATP to trigger P2X3R current was 3 nm, and the half-maximal inward current was produced by 39 nm. Other agonists also activated this receptor in nanomolar concentrations, with EC50 values ranging from 18 to 243 nm in the following order: 2MeSATP < ATP < BzATP < αβ-meATP < ATPγS (Fig. 1C). The amplitudes of current responses induced by saturating concentrations of all of the agonist were highly comparable for parental receptors, indicating that the maximum fraction of receptors in the active state was close to 1, and that all of the drugs acted as full agonists.

In contrast to parental receptors, there was no experimental possibility to examine the dose-dependent effects of agonists on peak currents in single cells expressing chimeric P2X2a plus V60-F301X3 and P2X2b plus V60-F301X3 receptors because of almost irreversible desensitization of a large fraction of receptors after a single agonist application (see below). To generate dose-response curves for these receptors, cells were stimulated with a single agonist concentration, and curves were generated from five to eight experiments per dose. The threshold ATP concentration for activation of P2X2a/V60-F301X3 and P2X2b/V60-F301X3 chimeras was ∼5 nm, and the estimated EC50 value was 50 nm. Chimeric receptor also responded to other agonists in a concentration-dependent manner, with EC50 values ranging from 19 to 267 nm and with comparable peak amplitudes. Figure 1, B and C, illustrates the combined results for both receptors. However, the threshold for activation of P2X2a/V60-R180X3 chimera by ATP was 10-20 nm, and the estimated EC50 values for ATP and other agonists were between those at P2X3R and P2X2aR (Fig. 1B,C). These results indicate that the V60-F301 ectodomain sequence of P2X3R accounts for the ligand-selective profile of P2X3R and that both N and C halves of this sequence contribute to the efficacy of agonists.

Patterns of signaling by wild-type and chimeric P2XRs

The time course of P2X3R current was dependent on agonist concentration and duration of stimuli. In a concentration range of 10-100 nm, the sustained ATP application usually generated a biphasic response. As shown in Figure 2A, during repetitive stimulation with 10 nm ATP (60 or 30 sec followed by 30 sec washing period), a biphasic response was present only during the first ATP pulse. Removal of ATP was followed by a rapid and monoexponential decline in current. The decay of P2X3R current evoked by removal of 10 nm ATP was well fitted by a single exponential function, with τoff of 506 ± 18 msec (n = 12). Both the decline in current after removal of agonist and the rise in current after restimulation of cells indicate that τoff reflects P2X3R deactivation. However, there was a gradual decrease in peak response during repetitive stimulation with 10 nm ATP, indicating a slow desensitization of receptor (Fig. 2A). At higher (100 nm to 5 μm) concentrations, only monophasic responses were observed, and these responses rapidly declined (Fig. 2B,C). Restimulation of cells resulted in currents, the peak amplitude of which were comparable with the plateau current induced by previous ATP pulse, indicating that the decrease in current during agonist stimulation reflects desensitization of receptors. At 5 μm (Fig. 2D) and higher ATP concentrations, P2X3R current completely desensitized within 10 sec. Consistent with literature (Lewis et al., 1995), in cells stimulated with 0.1-10 μm ATP, the P2X3R desensitization profile was best described by the sum of two exponentials. Both fast (τdes1) and slow (τdes2) desensitization time constants decreased with increase in ATP concentration (Fig. 2E). When stimulated with 1 μm ATP, the mean value of τdes1 was 0.55 ± 0.04 sec, and the mean value of τdes2 was 5.0 ± 0.45 sec; both fast and slow desensitization processes almost equally contributed to the decay in current (Table 1).

Figure 2.
Figure 2.

Concentration-dependent effects of ATP on P2X3R current activation, desensitization, and deactivation. A-C, Repetitive stimulation of cells with 10 nm (A), 100 nm (B), and 1 μm (C) ATP. D, Typical trace of rapidly desensitizing currents in response to 5 μm ATP. In this and the following figures, gray areas indicate the duration of agonist application. E, Inverse correlation between ATP concentrations and τdes1 (left) and τdes2 (right) values. Asterisks indicate significant differences between 0.1 and 1 or 10 μm. Values shown are mean ± SEM, with n between 4 and 16 per dose.

View this table:
Table 1.

Characterization of ATP-induced desensitization decays in parental and chimeric receptors

P2X2aR and P2X2bR also responded with biphasic nondesensitizing currents when stimulated with 100 nm to 5 μm ATP, and at higher ATP concentrations, these receptors usually responded with monophasic currents. In accordance with previously published data (Brandle et al., 1997; Simon et al., 1997; Koshimizu et al., 1998), P2X2aR and P2X2bR desensitized with different rates and to different plateau levels (Table 1). In response to stimulation with saturating (100 μm) ATP concentrations for 60 sec, P2X2aR partially desensitized with slow rates, whereas P2X2bR desensitized to higher degree and more rapidly (Fig. 3A). The desensitization decay for both receptors was usually described with the sum of two exponentials; τdes1 contributed to the desensitization decay of P2X2aR and P2X2bR on average by 25 and 50%, respectively (Table 1). Both currents declined rapidly after removal of ATP. The estimated τoff values after 60 sec stimulation with 10 μm ATP (a time sufficient to reach the equilibrium in current) were 294 ± 33 msec (n = 15) and 231 ± 19 msec (n = 9) for P2X2aR and P2X2bR, respectively. These values are in the range observed by others (Li et al., 1997), but in our experimental conditions, they should be considered with reservation, because the solution exchange time of perfusion system was too slow to accurately measure deactivation of P2X2Rs (see Materials and Methods).

Figure 3.
Figure 3.

Patterns of current signaling by P2X2R and chimeric receptors. A, Typical traces of P2X2bR (top trace) and P2X2aR (bottom trace) currents induced by 40 sec application of 100 μm ATP. B, Current signaling by P2X2a/V60-R180X3 chimera induced by 30 sec application of 1 μm ATP. C, Superimposed responses of P2X2a/V60-F301X3 and P2X2b/V60-F301X3 chimeras to 40 sec application of 1 μm ATP.

At lower ATP concentrations, chimeric receptors also consistently responded with a biphasic pattern of signaling, and at higher concentrations, monophasic desensitizing responses were observed. P2X2a/V60-R180X3 desensitized in a manner comparable with that observed in cells expressing parental P2X2aR. Figure 3B illustrates a typical time course of current in response to 1 μm ATP. The desensitization decay for this receptor was also best fitted with the sum of two exponentials, and the slow desensitizing component was dominant (Table 1). After a 60 sec application of 1 μm ATP, when the equilibrium in current was usually reached, there was a relatively rapid return to basal level, indicating that, for this receptor, the decay in current after removal of ATP reflected the deactivation of channels. In 72% of cells, the ATP-induced current declined monoexponentially with a τoff value of 0.87 ± 0.17 sec. In residual cells, a biexponential function was the best fit for the decay of current and the second component was in the range of 5-8 sec and contributed to the decay of current by <20%.

Similar to parental P2X2aR and P2X2bR, chimeric P2X2a/V60-F301X3 and P2X2b/V60-F301X3 receptors also desensitized with different rates (Fig. 3C). P2X2b/V60-F301X3 desensitized rapidly and monoexponentially in response to 1 μm ATP, and the desensitization of the P2X2a/V60-F301X3 chimera was best described by the sum of two exponentials, and the slow component was dominant (Table 1). However, two chimeric channels differed from parental receptors with respect to the plateau response and the decay of response after removal of agonist. Whereas the P2X2aR and P2X2bR desensitization current reached plateau after 60-90 sec of agonist application (Table 1), P2X2a/V60-F301X3 and P2X2b/V60-F301X3 currents declined to basal level during the sustained agonist stimulation. Practically, the P2X2a/V60-F301X3 current declined to zero during 2 min exposure to 10 μm ATP, and P2X2b/V60-F301X3 reached zero level within 30 sec of stimulation with 10 μm ATP. Furthermore, no obvious changes in the profile of currents were observed after removal of ATP in these chimera-expressing cells (Fig. 3C). Thus, although the ATP potency for P2X3R and P2X2a/V60-F301X3 and P2X2b/V60-F301X3 chimeras was comparable, there was >65-fold difference in the rates of current decay between parental and chimeric receptors after agonist removal, indicating that the transfer of the V60-F301 sequence in the backbone of P2X2Rs affects the deactivation properties of receptors.

Agonist-dependent gating-deactivation coupling

The receptor specificity of current decays after agonist withdrawal was practically independent of duration of ATP pulse. Figure 4A illustrates that P2X3R current declined rapidly after 10 nm ATP application of different duration. The other parental receptor also deactivated rapidly and independently of duration of ATP pulse (Fig. 4B). Similarly, P2X2a/V60-R180X3 currents declined with comparable rates after ATP application of variable duration (data not shown). The delay in P2X2a/V60-F301X3 (Fig. 4C) and P2X2b/V60-F301X3 (D) current decays was also observed after shorter ATP application.

Figure 4.
Figure 4.

Independence of decay of currents after agonist withdrawal of duration of stimuli. Typical patterns of P2X3 (A), P2X2a (B), P2X2a/V60-F301X3 (C), and P2X2b/V60-F301X3 (D) current decays in response to ATP pulses of variable duration.

A more detailed analysis of the kinetics of P2X2a/V60-F301X3 and P2X2b/V60-F301X3 current decays after a prolonged (60 sec) and brief (2 sec) stimulation with 1 μm ATP is shown in Figure 5. The derived time constants (shown below traces) from fitting curves (shown by dotted lines) reflect the rates of receptor desensitization (left panels) and the rates of current decay after washout of ATP (right panels). The similarity in τdes and τoff values for both chimeras is consistent with a hypothesis that, once activated, P2X2a/V60-F301X3 and P2X2b/V60-F301X3 receptors undergo desensitization rather than deactivation. Because the desensitization of P2X2b/V60-F301X3 current was very rapid and was practically impossible to fit the deactivation currents recorded after sustained agonist application, in additional studies, we used the slow desensitizing P2X2a/V60-F301X3 and P2X2a/V60-R180X3 chimeras as receptor models to study the deactivation and resensitization properties of channels.

Figure 5.
Figure 5.

Comparison of decay rates of P2X2a/V60-F301X3 (A) and P2X2b/V60-F301X3 (B) currents during the long-term (left traces) and short-term (right traces) stimulation with 1 μm ATP. Gray traces represent experimental records, and black dotted lines illustrate fitting curves (see Materials and Methods). The decay time constants are shown below traces. Bars above traces indicate the duration of ATP application.

The dose-dependent studies revealed relatively rapid decays in P2X2a/V60-R180X3 current, but not P2X2a/V60-F301X3 current, in all of the concentrations of ATP tested (Fig. 6A,C). Basically, there was ∼30-fold difference in τoff values for two chimeric receptors, reinforcing the conclusion that the C half of ectodomain is critical for changes in deactivation properties of the P2X2a/V60-F301X3 chimera. Furthermore, for both chimeras, there was an increase in τoff values with increase in ATP concentrations (Fig. 6B,D).

Figure 6.
Figure 6.

Concentration-dependent effects of ATP on the patterns of P2X2a/V60-R180X3 (A, B) and P2X2a/V60-F301X3 (C, D) current signaling. A, Representative traces of P2X2a/V60-R180X3 current from a single cell obtained during repetitive stimulation with increasing concentrations of ATP applied at 10 min interval. B, Correlation between ATP concentrations and τoff values for P2X2a/V60-R180X3 (mean ± SEM values, with n between 4 and 26 per dose). C, Representative traces of P2X2a/V60-F301X3 current from different cells. D, Correlation between ATP concentrations and τoff values for P2X2a/V60-F301X3 current induced by 2 sec stimulation (mean ± SEM values, with n between 5 and 24 per dose). For correlation analysis, τoff values were derived from monoexponential and biexponential fittings (for records induced by higher ATP doses) using the dominant τoff1 component.

To test the agonist specificity of decays in currents after their washout, in additional experiments, cells expressing P2X2a/V60-R180X3 and P2X2a/V60-F301X3 chimeras were stimulated with different agonists for a brief period. Figure 7A illustrates the ligand specificity in the pattern of P2X2a/V60-R180X3 current decays after 5 sec agonist stimulation. In all of the cases, currents declined to basal level relatively rapidly. In addition, there were ligand-specific differences in the rates of P2X2a/V60-R180X3 current decay after washout of agonists, in the following order (from slow to fast declining): 2MeSATP > ATP > BzATP > αβ-meATP > ATPγS. The decay of P2X2a/V60-F301X3 current after application of agonists for 2 sec was also ligand specific and occurred in the same rank order as in P2X2a/V60-R180X3-expressing cells (Fig. 7B). For both chimeras, the decay of currents induced by withdrawal of 2MeSATP and ATP was best fitted with double exponential functions, whereas monoexponential functions were best fits for decay of currents after washout of agonists with lower potency. As in dose-response studies with ATP, the rates of P2X2a/V60-F301X3 current decays were always 4- to 24-fold slower than for P2X2a/V60-R180X3 current. Because both P2X2a/V60-R180X3 and P2X2a/V60-F301X3 chimeras exhibited similar rank orders in their EC50 values for agonists (Fig. 1C), these results indicate that the rate of current decay after agonist washout was influenced by ligand potency, but in a receptor-specific manner.

Figure 7.
Figure 7.

Agonist-specific decays in P2X2a/V60-R180X3 (A) and P2X2a/V60-F301X3 (B) currents after short-term stimulation. Traces shown in A are from a single cell obtained during repetitive stimulation at 10 min interval, whereas traces shown in B are from different cells. The biexponential functions were the best fit for the effect of agonist withdrawal in all of the experiments with 2MeSATP and in a fraction of cells (35%) with ATP applications. For all of the other agonists, the monoexponential functions were the best fit, and τoff values were indicated below traces. Peak currents are shown as 1.

The finding that decays of P2X2a/V60-F301X3 currents are considerably faster after removal of αβ-meATP and ATPγS compared with high-affinity agonists (Fig. 7B), prompted us to further examine the effects of these two agonists on current desensitization and deactivation. As shown in Figure 8A, the P2X2a/V60-F301X3 chimera desensitized slowly during sustained stimulation with 1 μm ATPγS, and the decay could not be fitted with an exponential function. However, the washout of this agonist induced a decline in current with a time constant of 5 sec (Fig. 8A), indicating that the majority of receptors deactivate when ATPγS was removed (see also Fig. 10C). Furthermore, 0.1 μm αβ-meATP triggered a moderate desensitization of chimeric receptor, which could be fitted by a monoexponential function with plateau, and removal of agonist near the equilibrium induced an additional decline in current (Fig. 8B). These results clearly indicate that deactivation also participates in the decay of P2X2a/V60-F301X3 current after washout of lower affinity agonists.

Figure 8.
Figure 8.

Dissociation between desensitization and deactivation rates of P2X2a/V60-F301X3 chimera. A, B, Relatively fast deactivation of P2X2a/V60-F301X3 chimera after washout of nondesensitizing ATPγS (A) and comparable desensitization (τdes) and deactivation (τoff) time constants of P2X2a/V60-F301X3 chimera elicited by αβ-meATP (B). The decay of current in the presence of αβ-meATP was fitted by a monoexponential function with a plateau at 52% of the peak current. C, Inverse linear-log correlation between EC50 and τoff values. D, Linear relationship between EC50 and τdes2 values. The τdes and τoff values were derived from experiments in which receptors were stimulated with saturating (1 μm) concentrations of five agonists for 60 and 2-5 sec, respectively. Data points and bars represent mean ± SEM values, with n = 4-20 per agonist.

Figure 10.
Figure 10.

Recovery from desensitization of chimeric receptors. A-C, Patterns of P2X2a/V60-F301X3 current signaling during repetitive stimulation with 1 μm ATP (A), 10 μm ATP (B), and 1 μm ATPγS(C). D, P2X2a/V60-R180X3 current signaling induced by repetitive application of 10 μm ATP. Gray areas indicate the duration of agonist application. The rates of current deactivation are shown in Table 2.

We also correlated the EC50 values for agonists with the corresponding τoff and τdes values for the P2X2a/V60-F301X3 chimera. The desensitization rates were calculated during the 30-60 sec stimulation, and τoff values were derived from experiments with 2 sec stimulation with saturating concentrations of agonists. As shown in Figure 8, there was an inverse linear-log relationship between EC50 values and the corresponding τoff values (Fig. 8C), in contrast to a linear relationship between EC50 values and slow dominant τdes values for these agonists (D). The τoff values also inversely correlated with the τdes values (r = 0.98 for the log-linear correlation), further indicating that the decay in P2X2a/V60-F301X3 current after washout of high-potency agonists predominantly reflects continuous desensitization of receptor, whereas the decay in current after withdrawal of low-potency agonists predominantly reflects slow deactivation of chimera.

Finally, we compared the EC50 values for ATP and ATPγS with deactivation kinetics of receptors to clarify whether the chimerization-induced shift in EC50 values for these agonists parallels changes in the rate of receptor deactivation. To reduce the participation of desensitization to the decay of currents, the washout of agonists was initiated when the plateau in current was reached or application of nondesensitizing agonist concentrations was used. As shown in Table 2, a significant increase in EC50 value for ATP at P2X2a/V60-R180X3 chimera compared with parental P2X3R was not accompanied with a decrease in τoff. Because the equilibrium in decay of P2X2a/V60-F301X3 chimera could not be reached during sustained ATP stimulation, it was incorrect to compare EC50 and τoff values at P2X3R and the P2X2a/V60-F301X3 chimera. However, this was not the case with ATPγS, a low-potency agonist for three receptors. Both P2X3R and P2X2a/V60-F301X3 chimera exhibited highly comparable EC50 values for this agonist, but deactivation of P2X2a/V60-F301X3 chimera was 5.8-fold slower than of the wild-type channel. Furthermore, P2X2a/V60-R180X3 chimera exhibited a significantly higher EC50 value for ATPγS, but deactivated with rates comparable with that observed in P2X3R-expressing cells (Table 2). These findings indicate that the P2XR-specific transition from open to closed state, but not the removal of agonist from the ligand-binding domain, represents the rate-limiting step for receptor deactivation.

View this table:
Table 2.

The lack of correlation between EC50 and τoff values for P2X3, P2X2a/V60-F301X3, and P2X2a/V60-R180X3 receptors in response to ATP and ATPγS stimulation

Recovery from desensitization

To estimate the recovery time for parental and chimeric receptors, cells were stimulated repetitively with 30-60 sec of ATP or ATPγS pulses, with a progressive increase in the interpulse intervals (Fig. 9A,C). The ATP pulses were sufficient to almost completely desensitize P2X2bR and P2X3R, whereas the extent of P2X2aR desensitization at plateau was ∼25% (Table 1). The recovery of P2X2bR from desensitization occurred monoexponentially, with a time constant (τrec) of 55 sec (Fig. 9B), and the desensitized portion of P2X2aR current recovered with a similar time constant (data not shown). However, the P2X3R recovered with a τrec value of 141 sec (Fig. 9D).

Figure 9.
Figure 9.

Recovery from desensitization of parental receptors. A, C, The example records showing P2X2b (A) and P2X3 (C) current desensitization during 60 sec application of 10 μm ATP and recovery of response to ATP after different washout times (10, 20, 30, 90, 120, 240, and 480 sec). The bars above traces indicate time of ATP application. B, D, Recovery of responses to ATP in P2X2bR (B)- and P2X3R (D)-expressing cells, shown as the peak/first peak response and plotted as a function of washing time. Data (means ± SEM; n = 3-5) were fitted as described in Materials and Methods.

Repetitive stimulation of P2X2a/V60-F301X3 chimera with 30 sec pulses of 1 μm ATP led to a progressive decrease in response. As shown in Figure 10A, the current did not decline to basal level during the first three pulses, indicating continuous desensitization of receptors between ATP stimuli. Receptors showed only a partial recovery of response with increase in the interpulse periods (Fig. 10A). The full recovery of response was never reached within up to 40 min of washing period. The involvement of desensitization in the decay of responses to short stimulation with high ATP concentration was also reexamined. When stimulated with 10 μm ATP for 2 sec, followed by a 9.5 min washing period, the subsequent ATP pulse generated a signal, of which the amplitude was only 44% of the first peak response (Fig. 10B). When the washing period was decreased to 1 min, the recovery of response was 21%. These data confirmed that the main component in decay of P2X2a/V60-F301X3 currents after washout of ATP was attributable to desensitization of channels.

In contrast to ATP, a prolonged stimulation with 1 μm ATPγS only partially desensitized the P2X2a/V60-F301X3 chimera (Fig. 10C). Furthermore, removal of agonist was followed by a relatively rapid decay in current, and there was almost complete recovery of the nondesensitizing component of P2X2a/V60-F301X3 current when the interpulse interval was >30 sec. These data confirmed that the main component in decay of P2X2a/V60-F301X3 currents after washout of ATPγS was attributable to deactivation of receptors. However, there was no recovery of receptors from desensitization during tens of minutes after washout of ATPγS, indicating that not only the stability of gating state but also the stability of desensitized conformation state is enhanced in the P2X2a/V60-F301X3 chimera.

The recovery from the desensitization state of the P2X2a/V60-R180X3 chimera, which deactivated more rapidly than the P2X2a/V60-F301X3 chimera, was also dramatically extended. Figure 10D illustrates that recovery of a nondesensitized component of P2X2a/V60-R180X3 current was fast, whereas the interpulse intervals between 30 sec and 4 min were practically ineffective in resensitizing receptors. As with the P2X2a/V60-F301X3 chimera, the extension of washing periods up to 40 min was not sufficient for full recovery from the desensitized state. These findings indicate that the N half of the P2XR ectodomain region is influencing the stability of the desensitized conformation state.

Discussion

Here, we studied the gating properties of three chimeras to understand the influence of ectodomain structure and agonist potency on desensitization, deactivation, and resensitization of P2XRs. In our experimental conditions, the patterns of activation and desensitization of parental receptors were in general agreement with the literature (North, 2002). Furthermore, the estimated EC50 values for agonists at P2X2Rs found here were only slightly leftward shifted compared with other studies (Brake et al., 1994; King et al., 1996; Werner et al., 1996; Brandle et al., 1997; Zhou et al., 1998). For P2X3R, differences were more significant; the reported EC50 values range from 0.2 to 1.8 μm (Chen et al., 1995; Lewis et al., 1995; Garcia-Guzman et al., 1997; Wildman et al., 1999), whereas in our experimental conditions, the estimated EC50 value for ATP was 0.04 μm.

Several factors could contribute to the differences in the estimated EC50 values at P2X2R and P2X3R. Recombinant receptors were studied when expressed in different cell types, and the host cells could influence the responses. In our experimental conditions, HEK293 (present study) and GT1 cells (He et al., 2002) expressing P2X3R responded to ATP stimulation only if rapidly perfused with ATP-free medium for at least 10 min before recording or cultured in the presence of apyrase, an ectonucleotidase. Consistent with this, GT1 and HEK293 cells release ATP under resting conditions (He et al., 2004). Mammalian cells express one or several ectonucleotidase subtypes, which could compete with P2XRs for ATP at the plasma membrane (Zimmermann, 2000; Joseph et al., 2003). The estimated EC50 values for ATP thus may reflect the equilibrium between supply of ATP and its degradation. At low agonist concentrations, ectonucleotidase activity may also contribute to the generation of a biphasic response during the initial ATP application (Zemkova et al., 2003). It has also been suggested that this phenomenon might be attributable to a history-dependent increase in permeability of the pore (Khakh et al., 1999; Virginio et al., 1999).

As we reported previously (He at al., 2002), the substitution of native I66-H192 sequence with V60-R180 sequences of P2X3R resulted in a leftward shift in the EC50 values for ATP, BzATP, and ATPγS at chimeric channels compared with parental P2X2Rs. Here, we show that the sensitivity of P2X2a/V60-F301X3 and P2X2b/V60-F301X3 chimeras to ATP, 2MeSATP, BzATP, αβ-meATP, and ATPγS is practically indistinguishable from that observed at P2X3R, suggesting that the selected ectodomain sequence of P2X3R is sufficient to preserve the potency of agonists for receptors. The finding that EC50 values for agonists at P2X2a/V60-R180X3 chimera were between those observed at parental receptors, further indicates that both N and C halves of ectodomain participate in gating of P2XRs. This is in general accordance with studies showing that several residues in both ectodomain halves significantly affect the gating of receptors (Jiang et al., 2001; Roberts and Evans, 2004).

Changes in the ectodomain structure of P2X2Rs also affected the rates of deactivation and recovery from desensitization states. The decay of current after removal of agonist is commonly used as a measure of receptor deactivation and in nondesensitizing receptors reflects the transition from open to closed conformation, followed by dissociation of the agonist from the closed channel. The decay in P2X2a/V60-F301X3 and P2X2b/V60-F301X3 currents after agonist withdrawal was 15-200 times delayed. However, there was only a threefold delay in the decay of P2X2a/V60-R180X3 current after ATP withdrawal compared with parental P2X2aR, indicating the relevance of the ectodomain C half in the stability of the open conformation state. Furthermore, the delay in P2X2a/V60-F301X3 current decay was dependent on the agonist used to activate receptors, but was not influenced by the duration of the agonist stimulation. Finally, the decay in currents reflected continuous desensitization and deactivation of receptors, and participation of deactivation in closure of channels inversely correlated with the potency of the agonists to activate receptor. Thus, changes in the stability of the open state could reflect on the probability of channels to enter the desensitized state after washout of agonist.

As discussed recently by Rettinger and Schmalzing (2004), one may propose two scenarios for deactivation of nondesensitizing P2XRs: (1) a channel-inherent slow transition from open to closed state, followed by a faster dissociation of agonist from receptor, or (2) fast channel closure, followed by slow dissociation of agonist from receptor. In both scenarios, the experimentally observed time course of current deactivation ultimately reflects agonist unbinding, but it does not clarify which transition is the rate-limiting step for this process (Colquhoun, 1998). Previously published studies by Hibell et al. (2001) revealed that the P2X7R closure time was dependent on agonist potency. Rettinger and Schmalzing (2004) also found that the EC50 values for several agonists at a P2X2/X1 chimera containing the ectodomain of P2X1R inversely correlated with the rate of current decay after washout of the corresponding agonist, and suggested that agonist dissociation represents the rate-limiting step for current deactivation. As the authors stated, this conclusion should be taken with reservation, because they were unable to measure the deactivation properties of parental P2X1R because of their rapid and complete desensitization.

We also observed a correlation between EC50 values for several agonists and their τoff values for P2X2a/V60-F301X3 and P2X2a/V60-R180X3 chimeras and P2X3R, when analyzed separately, but in our experiments, the chimerization-induced shift in EC50 values for agonists did not reflect on rates of receptor deactivation. In contrast, a decrease in the potency of ATP and ATPγS for P2X2a/V60-R180X3 chimera compared with P2X3R was not accompanied with a decrease in τoff. Furthermore, although P2X3R and P2X2a/V60-F301X3 chimera have the same V60-F301 ectodomain sequence and ATPγS was equipotent for two receptors, deactivation of the P2X2a/V60-F301X3 chimera was significantly slower than of the wild-type channel. In accordance with our findings, the affinity of agonists for P2X7R is lower compared with P2X3R and P2X2R (North, 2002), but this channel deactivates with a time constant in seconds (Klapperstuck et al., 2001).

These results strongly argue against the hypothesis that agonist dissociation from its binding site represents the rate-limiting step for P2XR current deactivation. Our findings are more consistent with the general view for ligand-gated receptor channels that conformation changes associated with gating do not allow agonist dissociation (Chang and Weiss, 1999). We suggest that the stability of the open conformation state for P2XRs reflects on deactivation kinetics and dissociation of agonist from receptors. The gating-associated lock of agonists onto P2X2a/V60-F301X3 and P2X2b/V60-F301X3 chimeric channels lasts from three to tens of seconds, further indicating the potential validity of chimeras in studies on dissociation of ligands from receptors using radioligand-receptor binding measurements.

The observation that P2X2Rs and P2X3R recovered from desensitization completely and in a relatively short period (τrec, 2.3 min) suggests that internalization, which is a receptor-specific phenomenon and usually requires longer time periods (Ennion and Evans, 2001; Bobanovic et al., 2002), probably did not significantly participate in P2X2R and P2X3R desensitization and recovery from desensitization. Others have also observed recovery of P2X3R with similar τrec (Sokolova et al., 2004). However, the full recovery from desensitization of P2X2a/V60-F301X3 chimeras needs >40 min, indicating that chimerization enhances the stability of the desensitized state. In contrast to the deactivation of channels, resensitization of chimeric channels is probably not a ligand-specific phenomenon. In addition, although P2X2a/V60-F301X3 and P2X2a/V60-R180X3 chimeras deactivated with different rates, they exhibited comparable rates of recovery from desensitization. This finding suggests the relevance of the N half of the ectodomain in conformation changes associated with desensitization and narrows the number of potential residues in additional site-directed mutagenesis studies. Because P2X3R has the same sequence, but fully recovers within 10-15 min, these results further indicate that the intramolecular interactions between the N half of the ectodomain sequence and other regions of the same subunits or between the subunits accounts for the specificity of receptor action.

In conclusion, we show here that the insertion of P2X3R ectodomain in the backbone of P2X2aR and P2X2bR effectively transfers the ligand-binding properties of P2X3R to chimeric channels (in terms of potency of agonists), indicating the relevance of both ectodomain halves in ligand binding. Our results further indicate that changes in the receptor architecture made by chimerization dramatically increase the stability of opened and desensitized conformation states, as indicated by slow deactivation of receptors and recovery from desensitization after washout of agonist. The findings with chimeras that both ectodomain halves participate in gating, but that the C half influences stability of open conformation state and the N half of the ectodomain influences stability of the desensitized state, support the view that the occupancy of at least two binding sites is required for conformation transitions between the resting, conducting, and desensitized states of P2XRs.

Footnotes

  • We thank Dr. Melanija Tomic for critical reading of this manuscript.

  • Correspondence should be addressed to Dr. Stanko Stojilkovic, Endocrinology and Reproduction Research Branch, National Institute of Child Health and Human Development, National Institutes of Health, Building 49, Room 6A-36, 49 Convent Drive, Bethesda, MD 20892-4510. E-mail: stankos{at}helix.nih.gov.

  • H. Zemkova's present address: Institute of Physiology, Academy of Sciences of the Czech Republic, 142 20 Prague 4, Czech Republic.

  • Copyright © 2004 Society for Neuroscience 0270-6474/04/246968-11$15.00/0

References

  1. ↵
    Bean BP (1990) ATP-activated channels in rat and bullfrog sensory neurons: concentration dependence and kinetics. J Neurosci 10: 1-10.
    OpenUrlAbstract
  2. ↵
    Bobanovic L, Royle SJ, Murrell-Lagnado RD (2002) P2X receptor trafficking in neurons is subunit specific. J Neurosci 22: 4814-4824.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Boue-Grabot E, Archambault V, Seguela P (2000) A protein kinase C site highly conserved in P2X subunits controls desensitization kinetics of P2X2 ATP-gated channels. J Biol Chem 275: 10190-10195.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Brake AJ, Wagenbach MJ, Julius D (1994) New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature 371: 519-523.
    OpenUrlCrossRefPubMed
  5. ↵
    Brandle U, Spielmanns P, Osteroth R, Sim J, Surprenant A, Buell G, Ruppersberg JP, Plinkert PK, Zenner HP, Glowatzki E (1997) Desensitization of the P2X2 receptor controlled by alternative splicing. FEBS Lett 404: 294-298.
    OpenUrlCrossRefPubMed
  6. ↵
    Chang Y, Weiss DS (1999) Channel opening locks agonist onto the GABAC receptor. Nat Neurosci 2: 219-225.
    OpenUrlCrossRefPubMed
  7. ↵
    Chen C-C, Akopian AN, Sivilotti L, Colquhoun D, Burnstock G, Wood JN (1995) A P2X purinoreceptor expressed by a subset of sensory neurons. Nature 377: 428-431.
    OpenUrlCrossRefPubMed
  8. ↵
    Clarke CE, Benham CD, Bridges A, George AR, Meadows HJ (2000) Mutation of histidine 286 of the human P2X4 purinoreceptor removes extracellular pH sensitivity. J Physiol (Lond) 523: 697-703.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Coddou C, Morales B, Gonzalez J, Grauso M, Cordillo F, Bull P, Rassendren F, Huidobro-Toro JP (2003) Histidine 140 plays a key role in the inhibitory modulation of the P2X4 nucleotide receptor by copper but not zinc. J Biol Chem 278: 36777-36785.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Colquhoun D (1998) Binding, gating, affinity and efficacy: the interpretation of structure-activity relationship for agonists and of the effects of mutating receptors. Br J Pharmacol 125: 924-947.
    OpenUrlCrossRefPubMed
  11. ↵
    Egan TM, Haines WR, Voigt MM (1998) A domain contributing to the ion channel of ATP-gated P2X2 receptors identified by the substituted cysteine accessibility method. J Neurosci 18: 2350-2359.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Ennion SJ, Evans RJ (2001) Agonist-stimulated internalisation of the ligand-gated ion channel P2X1 in rat vas deferens. FEBS Lett 489: 154-158.
    OpenUrlCrossRefPubMed
  13. ↵
    Garcia-Guzman M, Stuhmer W, Soto F (1997) Molecular characterization and pharmacological properties of the human P2X3 purinoreceptor. Brain Res Mol Brain Res 47: 59-66.
    OpenUrlPubMed
  14. ↵
    He M-L, Koshimizu T, Tomic M, Stojilkovic SS (2002) Purinergic P2X2 receptor desensitization depends on coupling between ectodomain and C-terminal domain. Mol Pharmacol 62: 1187-1197.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    He M-L, Zemkova H, Koshimizu T, Tomic M, Stojilkovic SS (2003) Intracellular calcium measurements as a method in studies on activity of purinergic P2X receptor channels. Am J Physiol 285: C467-C479.
    OpenUrl
  16. ↵
    He M-L, Iglesias-Gonzalez A, Stojilkovic SS (2004) Release and extracellular metabolism of ATP by ectonucleotidase eNTPDase 1-3 in hypothalamic and pituitary cells. Paper presented at Fourth International Symposium of Nucleosides and Nucleotides, Chapel Hill, NC, June.
  17. ↵
    Hibell AD, Thompson KM, Simon J, Xing M, Humphrey PPA, Mitchel AD (2001) Species- and agonist-dependent differences in the deactivation-kinetics of P2X7 receptors. Naunyn Schmiedebergs Arch Pharmacol 363: 639-648.
    OpenUrlCrossRefPubMed
  18. ↵
    Jiang L-H, Rassendren F, Spelta V, Surprenant A, North RA (2001) Amino acid residues involved in gating identified in the first membrane-spanning domain of the rat P2X2 receptor. J Biol Chem 276: 14902-14908.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Joseph SM, Buchakjian MR, Dubyak GR (2003) Colocalization of ATP release sites and ecto-ATPase activity at the extracellular surface of human astrocytes. J Biol Chem 278: 23331-23342.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    Khakh BS, Proctor WR, Dunwiddie TV, Labarca C, Lester HA (1999) Allosteric control of gating and kinetics at P2X4 receptor channels. J Neurosci 19: 7289-7299.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    Khakh BS, Burnstock G, Kennedy C, King BF, North RA, Seguela P, Voigt M, Humphrey PPA (2001) International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev 53: 107-118.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    King BF, Ziganshina LE, Pintor J, Burnstock G (1996) Full sensitivity of P2X2 purinoreceptor to ATP revealed by changing extracellular pH. Br J Pharmacol 117: 1371-1373.
    OpenUrlPubMed
  23. ↵
    Klapperstuck M, Buttner C, Schmalzing G, Markwardt F (2001) Functional evidence of distinct ATP activation sites at the human P2X7 receptor. J Physiol (Lond) 534: 25-35.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Koshimizu T, Tomic M, Van Goor F, Stojilkovic SS (1998) Functional role of alternative splicing in pituitary P2X2 receptor-channel activation and desensitization. Mol Endocrinol 12: 901-913.
    OpenUrlCrossRefPubMed
  25. ↵
    Koshimizu T, Koshimizu M, Stojilkovic SS (1999) Contributions of the C-terminal domain to the control of P2X receptor desensitization. J Biol Chem 274: 37651-37657.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    Koshimizu T, Ueno S, Tanoue A, Yanagihara N, Stojilkovic SS, Tsujimoto G (2002) Heteromultimerization modulates P2X receptor functions through participating extracellular and C-terminal subdomains. J Biol Chem 277: 46891-46899.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    Lester RA, Jahr CE (1992) NMDA channel behavior depends on agonist affinity. J Neurosci 12: 635-643.
    OpenUrlAbstract
  28. ↵
    Lewis C, Neidhart S, Holy C, North RA, Buell G, Surprenant A (1995) Co-expression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons. Nature 377: 432-435.
    OpenUrlCrossRefPubMed
  29. ↵
    Li C, Peoples RW, Weight FF (1997) Mg2+ inhibition of ATP-activated current in rat noduse ganglion neurons: evidence that Mg2+ decreases the agonist affinity of the receptor. J Neurophysiol 77: 3391-3395.
    OpenUrlAbstract/FREE Full Text
  30. ↵
    Nicke A, Baumert HG, Rettinger J, Eichele A, Lambrecht G, Mutschler E, Schmalzing G (1998) P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels. EMBO J 17: 3016-3028.
    OpenUrlAbstract
  31. ↵
    North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82: 1013-1067.
    OpenUrlAbstract/FREE Full Text
  32. ↵
    Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50: 413-492.
    OpenUrlAbstract/FREE Full Text
  33. ↵
    Rassendren F, Buell G, Newbolt A, North RA, Surprenant A (1997) Identification of amino acid residues contributing to the pore of a P2X receptor. EMBO J 16: 1446-3454.
    OpenUrl
  34. ↵
    Rettinger J, Schmalzing G (2004) Desensitization masks nanomolar potency of ATP at the P2X1 receptor. J Biol Chem 279: 6426-6433.
    OpenUrlAbstract/FREE Full Text
  35. ↵
    Roberts JA, Evans RJ (2004) ATP binding at human P2X1 receptor: contribution of aromatic and basic amino acids revealed using mutagenesis and partial agonists. J Biol Chem 279: 9043-9055.
    OpenUrlAbstract/FREE Full Text
  36. ↵
    Simon J, Kidd EJ, Smith FM, Chessell IP, Murrell-Lagnado R, Humphrey PPA, Barnard EA (1997) Localization and functional expression of splice variants of the P2X2 receptor. Mol Pharmacol 52: 237-248.
    OpenUrlAbstract/FREE Full Text
  37. ↵
    Sokolova E, Skorinkin A, Fabbretti E, Masten L, Nistri A, Giniatullin R (2004) Agonist-dependence of recovery from desensitization of P2X3 receptors provides a novel and sensitive approach for their rapid up or downregulation. Br J Pharmacol 141: 1048-1058.
    OpenUrlCrossRefPubMed
  38. ↵
    Virginio C, MacKenzie A, Rassendren FA, North RA, Surprenant A (1999) Pore dilation of neuronal P2X receptor channels. Nat Neurosci 2: 315-321.
    OpenUrlCrossRefPubMed
  39. ↵
    Werner P, Seward EP, Buell GN, North RA (1996) Domains of P2X receptors involved in desensitization. Proc Natl Acad Sci USA 93: 15485-15490.
    OpenUrlAbstract/FREE Full Text
  40. ↵
    Wildman SS, King BF, Burnstock G (1999) Modulatory activity of extracellular H+ and Zn2+ on ATP-responses at rP2X1 and rP2X3 receptors. Br J Pharmacol 128: 486-492.
    OpenUrlCrossRefPubMed
  41. ↵
    Zemkova H, He M-L, Stojilkovic SS (2003) Ectonucleotidases control the pattern of signaling by P2X receptor at nanomolar ATP concentrations. Soc Neurosci Abstr 29: 250.7.
    OpenUrl
  42. ↵
    Zhou Z, Monsma LR, Hume RI (1998) Identification of a site that modifies desensitization of P2X2 receptors. Biochem Biophys Res Commun 252: 541-545.
    OpenUrlCrossRefPubMed
  43. ↵
    Zimmermann H (2000) Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol 362: 299-309.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Email
Print
View Full Page PDF
Citation Tools
Respond to this article
Identification of Ectodomain Regions Contributing to Gating, Deactivation, and Resensitization of Purinergic P2X Receptors
Hana Zemkova, Mu-Lan He, Taka-aki Koshimizu, Stanko S. Stojilkovic
Journal of Neuroscience 4 August 2004, 24 (31) 6968-6978; DOI: 10.1523/JNEUROSCI.1471-04.2004
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo

Jump to section

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.